NO173061C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner

Info

Publication number
NO173061C
NO173061C NO895032A NO895032A NO173061C NO 173061 C NO173061 C NO 173061C NO 895032 A NO895032 A NO 895032A NO 895032 A NO895032 A NO 895032A NO 173061 C NO173061 C NO 173061C
Authority
NO
Norway
Prior art keywords
benzotiazolines
preparation
therapeutic active
analogy procedure
analogy
Prior art date
Application number
NO895032A
Other languages
English (en)
Norwegian (no)
Other versions
NO895032D0 (no
NO173061B (no
NO895032L (no
Inventor
Francois Audiau
Claude James
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8816548A external-priority patent/FR2640624B1/fr
Priority claimed from FR8909484A external-priority patent/FR2649705B2/fr
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of NO895032D0 publication Critical patent/NO895032D0/no
Publication of NO895032L publication Critical patent/NO895032L/no
Publication of NO173061B publication Critical patent/NO173061B/no
Publication of NO173061C publication Critical patent/NO173061C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO895032A 1988-12-15 1989-12-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner NO173061C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8816548A FR2640624B1 (fr) 1988-12-15 1988-12-15 Medicaments a base de derives de la benzothiazolamine-2, nouveaux derives et leur preparation
FR8909484A FR2649705B2 (fr) 1989-07-13 1989-07-13 Medicaments a base de derives de la benzothiazolamine-2, nouveaux derives et leur preparation

Publications (4)

Publication Number Publication Date
NO895032D0 NO895032D0 (no) 1989-12-14
NO895032L NO895032L (no) 1990-06-18
NO173061B NO173061B (no) 1993-07-12
NO173061C true NO173061C (no) 1993-10-20

Family

ID=26227051

Family Applications (1)

Application Number Title Priority Date Filing Date
NO895032A NO173061C (no) 1988-12-15 1989-12-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner

Country Status (11)

Country Link
EP (1) EP0374041B1 (sv)
JP (1) JPH0749425B2 (sv)
CA (1) CA2005592A1 (sv)
DE (1) DE68901859T2 (sv)
DK (1) DK169383B1 (sv)
ES (1) ES2043070T3 (sv)
FI (1) FI93108C (sv)
GR (1) GR3004937T3 (sv)
IE (1) IE64657B1 (sv)
NO (1) NO173061C (sv)
PT (1) PT92606B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2684992B1 (fr) * 1991-12-13 1994-02-04 Rhone Poulenc Rorer Sa Procede de preparation d'amino-2 nitro-7 benzothiazoles.
FR2684993B1 (fr) * 1991-12-13 1994-02-04 Rhone Poulenc Rorer Sa Procede de preparation de derives d'amino-2 nitro-4 benzothiazole et intermediaires.
FR2714828B1 (fr) * 1994-01-12 1996-02-02 Rhone Poulenc Rorer Sa Application du riluzole dans le traitement des maladies mitochondriales.
FR2726271B1 (fr) * 1994-10-26 1996-12-06 Rhone Poulenc Rorer Sa Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole
FR2741803A1 (fr) * 1995-12-01 1997-06-06 Rhone Poulenc Rorer Sa Application de 2-aminobenzothiazoles dans le traitement de la maladie de parkinson et des syndromes parkinsoniens
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
IL128718A0 (en) 1996-09-27 2000-01-31 Guildford Pharmaceuticals Inc Naaldase compositions
FR2774592B1 (fr) * 1998-02-06 2000-03-17 Rhone Poulenc Rorer Sa Application du 2-amino-6-trifluoromethoxybenzothiazole pour la prevention ou le traitement des dysfonctionnements du cervelet
AU4537500A (en) 1999-05-12 2000-12-05 Neurosearch A/S Ion channel modulating agents
EP1416931B1 (en) * 2001-08-13 2007-06-13 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Inhibitors of polyq-aggregation
CN110709386B (zh) * 2017-03-30 2022-06-07 凯瑞康宁生物工程（武汉）有限公司 双环杂芳基衍生物及其制备与用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2631163B2 (de) * 1976-07-10 1978-06-29 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von 2-Iminobenzothiazolen
FR2492258A1 (fr) * 1980-10-17 1982-04-23 Pharmindustrie Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
JPS63190880A (ja) * 1986-09-09 1988-08-08 Nippon Tokushu Noyaku Seizo Kk 新規ｎ−ベンゾチアゾリル−アミド類及び殺虫剤
US4826860A (en) * 1987-03-16 1989-05-02 Warner-Lambert Company Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents

Also Published As

Publication number Publication date
NO895032D0 (no) 1989-12-14
IE894008L (en) 1990-06-15
NO173061B (no) 1993-07-12
JPH02223571A (ja) 1990-09-05
EP0374041A1 (fr) 1990-06-20
GR3004937T3 (sv) 1993-04-28
IE64657B1 (en) 1995-08-23
DK633489A (da) 1990-06-16
JPH0749425B2 (ja) 1995-05-31
DK169383B1 (da) 1994-10-17
FI93108B (sv) 1994-11-15
ES2043070T3 (es) 1993-12-16
FI93108C (sv) 1995-02-27
NO895032L (no) 1990-06-18
DE68901859D1 (de) 1992-07-23
DE68901859T2 (de) 1993-01-14
DK633489D0 (da) 1989-12-14
EP0374041B1 (fr) 1992-06-17
PT92606A (pt) 1990-06-29
PT92606B (pt) 1995-09-12
FI895983A0 (sv) 1989-12-14
CA2005592A1 (fr) 1990-06-15

Similar Documents

Publication Publication Date Title
NO172801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater
NO168770C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO173017C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nor-statin- eller nor-cyklostatinpolypeptider
NO172045C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer
NO170629C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO168174C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolforbindelser
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
NO171913C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser
NO167026C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO169438C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO171856C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosinderivater
NO168299C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
NO172539C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser
NO173185C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoxalinforbindelser
NO173061C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner
NO170582C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser
NO171857C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2'-halomethyliden-adenosin-derivater
NO169069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO172802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyraner
NO172643C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzopyranolderivater
NO171847C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzenderivater
NO169648C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO168103C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aralkylimidazolderivater